Shanghao Liu, Xiaohan Chen, Xuanwei Jiang, Xiaochun Yin, Ginenus Fekadu, Chuan Liu, Yan He, Huihui Chen, Wenjing Ni, Ruiying Wang, Qing-Lei Zeng, Yuping Chen, Ling Yang, Ruihua Shi, Sheng-Hong Ju, Jie Shen, Jingli Gao, Linhua Zhao, Wai-Kit Ming, Victor W Zhong, Gao-Jun Teng, Xiaolong Qi
BACKGROUND: Noninvasive and early assessment of liver fibrosis is of great significance and is challenging. We aimed to evaluate the predictive performance and cost-effectiveness of the LiverRisk score for liver fibrosis and liver-related and diabetes-related mortality in the general population. METHODS: The general population from the NHANES 2017-March 2020, NHANES 1999-2018, and UK Biobank 2006-2010 were included in the cross-sectional cohort (n = 3,770), along with the NHANES follow-up cohort (n = 25,317) and the UK Biobank follow-up cohort (n = 17,259)...
March 26, 2024: Med